Mycophenolate mofetil in pyoderma gangrenosum

Journal of Dermatological Treatment

Volumn 15, Issue 5, 2004, Pages 303-307

  Lee, Michael R ^a   Cooper, A J ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Mycophenolate mofetil; Neutrophilic dermatotis; Prednisone; Pyoderma gangrenosum

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRIAMCINOLONE ACETATE;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIARRHEA; DISEASE COURSE; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; GRAM NEGATIVE INFECTION; HEADACHE; HEART PALPITATION; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SEPSIS; STAPHYLOCOCCUS INFECTION; ULCER HEALING;

AGED; AGED, 80 AND OVER; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; PYODERMA GANGRENOSUM;

EID: 7044220723     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630410020154     Document Type: Article

References (21)

1. Gardner LW, Acker DW, Triamcinolone and pyoderma gangrenosum. Arch Dermatol (1972) 106: 559-60.
2. Reich K, Vente C, Neumann C, Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol (1998) 139: 755-7.
3. Altman J, Mopper C, Pyoderma gangrenosum treated with sulfone drugs. Minn Med (1966) 49: 22-6.
4. Martin de Hijas C, del-Rio E, Gorospe MA et al, Large peristomal pyoderma gangrenosum successfully treated with cyclosporine and corticosteroids. J Am Acad Dermatol (1993) 29: 1034-5.
5. Newell LM, Malkinson FD, Pyoderma gangrenosum: response to cyclophosphamide therapy. Arch Dermatol (1983) 119: 477-86.
6. Breathnach SM, Wells GC, Valdimarsson H, Idiopathic pyoderma gangrenosum and impaired lymphocyte function: failure of azathioprine and corticosteroid therapy. Br J Dermatol (1981) 104: 567-73.
7. Hecker MS, Lebwohl MG, Recalcitrant pyoderma gangrenosum: treatment with thalidomide. J Am Acad Dermatol (1998) 38: 490-1.
8. Epinette WW, Parker CM, Jones EL, Greist MC, Mycophenolic acid for psoriasis. J Am Acad Dermatol (1987) 17: 962-71.
9. Goldblum R, Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol (1993) 11: 117-19.
10. Lipsky JL, Mycophenolate mofetil. Lancet (1996) 348: 1357-9.
11. Frieling U, Luger TA, Mycophenolate mofetil and leflunomid: promising compound for the treatment of skin diseases. Clin Exp Dermatol (2002) 27: 562-70.
12. McDonald CJ, Chemotherapy for psoriasis. Int J Dermatol (1975) 14: 563-74.
13. Allison AC, Eugui EM, Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev (1993) 136: 5-28.
14. Eugui EM, Almquist S, Muller CD, Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol (1991) 33: 161-73.
15. Silverman Kitchin JE, Keltz Pomeranz M, Pak G et al, Rediscovering mycophenolic acid: review article of its mechanism, side effects and potential use. J Am Acad Dermatol (1997) 37: 445-9.
16. Lynch SW, Roenigk HH Jr, Mycophenolic acid for psoriasis. Arch Dermatol (1977) 113: 1203-8.
17. Benez A, Fierlbeck G, Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil. Br J Dermatol (2001) 144: 638-9.
18. Sollinger HW, Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation (1995) 60: 225-32.
19. European Mycophenolate Mofetil Cooperative Study Group, Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet (1995) 345: 1321-5.
20. Satchell AC, Barnetson RS, Staphylococcal septicaemia complicating treatment of atopic dermatitis with mycophenolate. Br J Dermatol (2000) 143: 202-3.
21. Butani L, Palmer J, Baluarte HJ, Polinsky MS, Adverse effects of mycophenolate mofetil in paediatric renal recipients with presumed chronic rejection. Transplantation (1999) 68: 83-6.